Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00075829 · OUTCOME

Incidences of Graft Versus Host Disease (GVHD)

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) · Source last updated 2021-11-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of patients
Interval / dispersion
95% Confidence Interval
Time frame
Day 100

What was measured

Incidence and severity of GVHD will be scored according to the BMT clinical trials network Manual of Procedures.

Analysis population: GVHD was only assessed on the Auto-Allo arm for standard risk patients that completed second transplant

Groups in this outcome

Auto-Allo Standard Risk

Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Auto-Allo Standard Risk156

Reported measurements

Grades II-IV
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Allo Standard Risk26Not reported1933Not reported
Grades III-IV
Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Allo Standard Risk9Not reported414Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        19
        upper Limit
        33
        value
        26
    title
    Grades II-IV
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        4
        upper Limit
        14
        value
        9
    title
    Grades III-IV
denoms
  1. counts
    1. group Id
      OG000
      value
      156
    units
    Participants
description
Incidence and severity of GVHD will be scored according to the BMT clinical trials network Manual of Procedures.
dispersion Type
95% Confidence Interval
groups
  1. description
    Autologous transplant plus non-myeloablative allogeneic transplant for standard risk patients
    id
    OG000
    title
    Auto-Allo Standard Risk
param Type
NUMBER
population Description
GVHD was only assessed on the Auto-Allo arm for standard risk patients that completed second transplant
reporting Status
POSTED
time Frame
Day 100
title
Incidences of Graft Versus Host Disease (GVHD)
type
SECONDARY
unit Of Measure
percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice